Recruiting
A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
NCT07647510
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
- Locations
-
- Cinical Study Site Fayetteville, North Carolina, United States